INTRODUCTION

1
The Epidermal Growth Factor Receptor (EGFR) family of transmembrane tyrosine 2 kinase receptors is involved in diverse developmental programs, and dysregulation of EGFR Drosophila melanogaster has proven to be a valuable model for studying EGFR 17 signaling. The EGFR pathway is conserved in Drosophila, but has much less complexity and 18 redundancy than the mammalian system, with only four ligands, one receptor, and a single 19 downstream signal transduction pathway (Shilo, 2005) . Three of the ligands, Spitz (Spi), Keren 20 (Krn) and Gurken (Grk), resemble the canonical mammalian ligands and are produced as 21 transmembrane pro-proteins, while Vein (Vn) resembles the non-canonical mammalian 22 Neuregulin ligands and lacks a transmembrane domain (Schnepp et al., 1996) . Spi is required 23 for numerous processes throughout development (Rutledge et al., 1992) , acting redundantly with is palmitoylated normally, and a non-palmitoylatable form of Spi pro-protein (mSpiCS) is 8 cleaved (Miura et al., 2006) . 9 Spi, like the mammalian EGFR ligands, has been suggested to act as a diffusible 10 paracrine factor. Spi is secreted into the media when expressed in cultured cells (Lee et al., 11 2001; Schweitzer et al., 1995), and can act at a distance of three to four cell diameters in vivo 12 (Freeman et al., 1992; Golembo et al., 1996a). Palmitoylation results in strong membrane 13 association of Spi and has been proposed to concentrate it on the surface of secreting cells 14 (Miura et al., 2006) , restricting its range of action. Although the Spi pro-protein and the cleaved 15 ligand are both membrane-associated, only the latter is thought to signal. Our results confirm 16 previous reports that in contrast to mammalian EGFR ligands, Spi is incapable of signaling in its 17 transmembrane pro-protein form (Freeman, 1996; Pickup and Banerjee, 1999; Schweitzer et al., 18 1995). We therefore sought to understand the mechanism by which post-translational processing 19 controls Spi activity. We used a panel of chimeric proteins to show that structural features of the 20 extracellular domain do not prevent signaling by the pro-protein mSpi, and found that mSpi is in 21 fact capable of activating the receptor in tissue culture. Our data suggest that signaling by mSpi 2   Although Spi was originally thought to be a soluble diffusible ligand (Schweitzer et al.,   3 1995), our previous results suggested that palmitoylation at the N-terminal cysteine residue 4 tethers Spi to the cell membrane, restricting its diffusion (Miura et al., 2006) . If the palmitate 5 group directly inserts into the plasma membrane, this would place the N-terminus of Spi 6 proximal to the membrane ( Figure 1A, B) . In order to understand why the extracellular domain 7 of Spi (sSpi) is active when tethered to the membrane by a palmitate group but not when 8 anchored to the membrane by the transmembrane domain of the pro-protein, we first tested the 9 effect of substituting an exogenous transmembrane domain for the palmitate group. We fused To assess whether orientation is important for Spi activity, we generated the chimeric construct 28 Spi-Gli, in which the extracellular domain of Spi is fused at its C-terminus to the type I Like Nrt-Spi, Spi-Gli is transported to the plasma membrane of S2R+ cells, activates the EGFR 2 in the co-culture assay, and rescues Fas III expression in spi mutant embryoss ( Figure 1E , G, K). 3 Thus, Spi can activate the EGFR when membrane tethered in either the type I or the type II 4 orientation. 5 In the Nrt-Spi and Spi-Gli chimeras, a large extracellular domain separates the receptor- 6 binding EGF domain from the membrane, while in mSpi the EGF domain is located close to the 7 membrane. To test the importance of the distance between the EGF domain and the membrane, 8 we constructed the chimera Spi-CD2, in which the extracellular domain of Spi carrying the 9 palmitoylation-site mutation is fused at its C-terminus to the transmembrane domain of the rat In vivo, overexpression of sSpi stimulates strong EGFR activation, and palmitoylation is 17 essential for its activity (Miura et al., 2006) . To compare the activities of our transmembrane Spi 18 chimeras in vivo, we assayed their ability to activate the EGFR in larval imaginal discs. comparable to the other chimeric proteins in the wing disc ( Figure 2K-N) , suggesting that its 5 weaker activity is due to the proximity of the EGF domain to the membrane. Together, our tissue 6 culture and in vivo data demonstrate that Spi does not require palmitoylation for its activity when 7 it is tethered by a transmembrane domain. Moreover, its activity is not critically dependent on 8 either the orientation or the distance of the EGF domain from the cell membrane. 9 
RESULTS
1
Membrane-tethered forms of Spi can activate the EGFR
10
The Spi pro-protein does not activate the EGFR in vivo, even when it is not palmitoylated 11 Although overexpression of sSpi strongly activates the EGFR in vivo, overexpression of 12 the full-length pro-protein (mSpi) had no effect, even when its chaperone Star was coexpressed In contrast, Spi-CD2, which resembles mSpi in its type I orientation and short extracellular 18 domain, is able to activate the EGFR. Because Spi-CD2 lacks the N-terminal palmitoylation 19 site, we hypothesized that the presence of membrane tethers at both the N-terminus and C- 20 terminus of mSpi might promote a conformation that is unfavorable for signaling ( Figure 3A) . 21 To test whether unpalmitoylated mSpi can activate the EGFR, we ectopically expressed the confirming that endogenous uncleaved and unpalmitoylated pro-protein is inactive ( Figure 3I ). 3 Therefore, the inability of mSpi to activate the EGFR is independent of its palmitoylation state.
5
The Spi pro-protein accumulates on the cell surface and activates the EGFR in tissue culture 6 The failure of mSpi to activate the EGFR in vivo led us to consider the possibility that 7 mSpi is not trafficked to the plasma membrane. In order to visualize only protein on the cell 8 surface, we expressed Flag-tagged mSpi in cultured S2 cells and stained with anti-Flag antibody 9 under non-permeabilizing conditions. We were able to detect mSpi at the cell surface only in the 10 presence of co-expressed Star, which allows its export from the ER ( Figure 4A , B). The same 11 was true for mSpiCS, the palmitoylation site mutant ( Figure 4C , D). To verify that cell surface 12 staining is due to full-length Spi pro-protein and not to Spi processed by Rho and Rasp, we 13 repeated the experiment using the mSpi variant lacking the Rho cleavage site (mSpiAG) Localization at the cell membrane correlates with signaling activity 26 The results above suggest that mSpi is inherently capable of activating the EGFR, but is 27 prevented from doing so in vivo. In order to investigate the nature of this inhibition, we used an Figure 5H -J). These data suggest that productive signaling occurs in the basolateral 5 domain, and that localization of mSpi to the apical domain may render it inactive in vivo. 6 7 The Spi cytoplasmic domain is not sufficient for apical localization and inactivation 8 Despite their similar structures and almost identical extracellular domains, Spi-CD2 and 9 the unpalmitoylated pro-protein mSpiCS show differential activity and apical-basal localization. 10 To test whether the cytoplasmic domain of mSpi controls its trafficking and inhibits its signaling 11 ability, we used it to replace the cytoplasmic domain of Spi-Gli, creating Spi-Gli-Spi ( Figure   12 6A). In comparison to Spi-Gli, which was a strong activator of the pathway, Spi-Gli-Spi only 13 weakly activated the EGFR in vivo. Spi-Gli-Spi induced weak ectopic aos-lacZ expression in the they often elicit different responses from the processed ligands. We investigated why the 5 Drosophila EGFR ligand Spi is inactive in its pro-protein form (mSpi), even though the active 6 processed form (sSpi) is membrane-associated by a palmitate adduct. Our results show that sSpi 7 is capable of activating the receptor when tethered to the membrane by an exogenous 8 transmembrane domain in either orientation. Increased spacing between the receptor-binding 9 EGF domain and the membrane appears favorable but not essential for signaling. The mSpi pro- 10 protein is trafficked to the cell surface and can activate the EGFR in cultured cells, but not in 11 vivo. mSpi appears largely confined to the apical domain of imaginal disc cells and is observed 12 in puncta, whereas active Spi forms are uniformly distributed in the basolateral domain ( Figure   13 7A). The intracellular domain alone is not sufficient to direct a Spi chimera to the apical surface, 14 suggesting a possible role for the transmembrane domain in this process. Together, our results 15 suggest that mSpi pro-protein is structurally capable of signaling, but is prevented from 16 activating the EGFR in vivo by directed trafficking. Sorting of receptor and ligand to apical and basolateral domains 6 Although mSpi pro-protein is inactive in vivo, we found that it is capable of activating 7 the EGFR in cultured S2 cells. One possible explanation for this difference is that S2 cells, 8 unlike epithelial imaginal disc cells, lack polarity. In wing disc cells, the active Spi chimeras Figure 7B ). This model predicts that endocytosis would 13 promote release of the active ligand, and might also prevent signaling by the pro-protein. 14 Alternatively, mSpi might be exported from the Golgi to Rho-containing endosomes and 15 localized directly to the basolateral surface. In this case, the presence of mSpi on the apical 16 plasma membrane would result from its inappropriate accumulation in cells that lack Rho. 17 18 Pro-protein signaling 19 The signaling ability of mammalian EGFR ligand pro-proteins has been controversial. 20 Studies in vitro showed that TGF-α pro-protein carrying mutations in the metalloprotease 21 cleavage site could signal, but in vivo, mutation of the metalloprotease itself appeared to 
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